secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dermata Therapeutics, Inc. (DRMA)
CIK:        0001853816
Form:       8-K
Filed at:   2024-08-02T23:59:59+00:00
Accession:  0001654954-24-009903
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dermata Therapeutics ups ATM offering by $505K to $1.66M total
--------------------------------------------------------------

- Increased maximum aggregate offering price under ATM agreement with H.C. Wainwright by $505,000 to $1,662,761.
- Previously sold $1,157,247.99 of common stock under the June 7, 2024 Sales Agreement.
- Additional $505,000 of shares authorized under the current prospectus supplement.
- Legal opinion on share legality filed as Exhibit 5.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1853816/000165495424009903/0001654954-24-009903-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1853816/000165495424009903/drma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-24-009903

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer